Anuh Pharma Limited (NSE:ANUHPHR)
India · Delayed Price · Currency is INR 73.81
+0.83 (1.14%)
Apr 2, 2026, 3:29 PM IST
Anuh Pharma Market Cap
Anuh Pharma has a market cap or net worth of 7.36 billion as of April 2, 2026. Its market cap has decreased by -7.45% in one year.
Market Cap
7.36B
Enterprise Value
7.23B
Revenue
7.68B
Ranking
n/a
PE Ratio
17.60
Stock Price
73.81
Market Cap Chart
Since January 2, 2008, Anuh Pharma's market cap has increased from 219.45M to 7.36B, an increase of 3,254.10%. That is a compound annual growth rate of 21.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 7.36B | -8.75% |
| Dec 31, 2025 | 8.07B | -28.75% |
| Dec 31, 2024 | 11.32B | 54.09% |
| Dec 29, 2023 | 7.35B | 64.17% |
| Dec 30, 2022 | 4.48B | -15.60% |
| Dec 31, 2021 | 5.30B | -22.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orchid Pharma | 26.34B |
| Solara Active Pharma Sciences | 22.12B |
| Indoco Remedies | 17.29B |
| Windlas Biotech | 16.18B |
| Beta Drugs | 12.82B |
| Jagsonpal Pharmaceuticals | 12.43B |
| Ind-Swift Laboratories | 11.98B |
| Sakar Healthcare | 11.47B |